BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Presentation	Product	Chemical substance	Chapter	Items dispensed
Propranolol 16mg/5ml oral liquid 0204000R0AADEDE	Propranolol hydrochloride	Propranolol hydrochloride	Cardiovascular System	No data available
Propranolol 1mg/1ml solution for injection ampoules 0204000R0AAACAC	Propranolol hydrochloride	Propranolol hydrochloride	Cardiovascular System	No data available
Propranolol 2.5mg/5ml oral liquid 0204000R0AACSCS	Propranolol hydrochloride	Propranolol hydrochloride	Cardiovascular System	No data available
Propranolol 2.75mg/5ml oral liquid 0204000R0AACQCQ	Propranolol hydrochloride	Propranolol hydrochloride	Cardiovascular System	No data available
Propranolol 20mg/5ml oral liquid 0204000R0AACPCP	Propranolol hydrochloride	Propranolol hydrochloride	Cardiovascular System	No data available
Propranolol 22.5mg/5ml oral liquid 0204000R0AADGDG	Propranolol hydrochloride	Propranolol hydrochloride	Cardiovascular System	No data available
Propranolol 25mg/5ml oral liquid 0204000R0AACKCK	Propranolol hydrochloride	Propranolol hydrochloride	Cardiovascular System	No data available
Propranolol 2mg/5ml oral liquid 0204000R0AACUCU	Propranolol hydrochloride	Propranolol hydrochloride	Cardiovascular System	No data available
Propranolol 3.5mg/5ml oral liquid 0204000R0AACZCZ	Propranolol hydrochloride	Propranolol hydrochloride	Cardiovascular System	No data available
Propranolol 32mg/5ml oral liquid 0204000R0AADADA	Propranolol hydrochloride	Propranolol hydrochloride	Cardiovascular System	No data available
Propranolol 3mg/5ml oral liquid 0204000R0AACTCT	Propranolol hydrochloride	Propranolol hydrochloride	Cardiovascular System	No data available
Propranolol 4mg/5ml oral liquid 0204000R0AADHDH	Propranolol hydrochloride	Propranolol hydrochloride	Cardiovascular System	No data available
Propranolol 6mg/5ml oral liquid 0204000R0AADDDD	Propranolol hydrochloride	Propranolol hydrochloride	Cardiovascular System	No data available
Propranolol 80mg / Bendroflumethiazide 2.5mg capsules 0204000Q0AAAAAA	Propranol hydrochloride with diuretic	Propranolol hydrochloride with diuretic	Cardiovascular System	No data available
Propranolol 80mg/5ml oral liquid 0204000R0AACNCN	Propranolol hydrochloride	Propranolol hydrochloride	Cardiovascular System	No data available
Propylene glycol 20% / Lactic acid 3% in Gen Unguentum M crm 130201000AADNDN	Generic compound emollients	Other emollient preparations	Skin	No data available
Propylene glycol 20% / Lactic acid 5% in Gen Unguentum M crm 130201000AADPDP	Generic compound emollients	Other emollient preparations	Skin	No data available
Propylene glycol 20% in Aqueous cream 130201000AACMCM	Generic compound emollients	Other emollient preparations	Skin	No data available
Propylene glycol 20% in Clobetasol 0.05% cream 130400000AABKBK	Generic compound preparation BNF 1304000	Other topical corticosteroid preparations	Skin	No data available
Propylene glycol 25% in Aqueous cream 130201000AADIDI	Generic compound emollients	Other emollient preparations	Skin	No data available
Propylene glycol 30% in Generic Unguentum M cream 130201000AADKDK	Generic compound emollients	Other emollient preparations	Skin	No data available
Propylene glycol 40% in Generic Unguentum M cream 130201000AADCDC	Generic compound emollients	Other emollient preparations	Skin	No data available
Propylene glycol 50% in Aqueous cream 130201000AADFDF	Generic compound emollients	Other emollient preparations	Skin	No data available
Propylene glycol 50% in Clobetasol 0.05% cream 130400000AABHBH	Generic compound preparation BNF 1304000	Other topical corticosteroid preparations	Skin	No data available
Propylene glycol 50% in Clobetasol 0.05% ointment 1304000G0AACWCW	Clobetasol propionate	Clobetasol propionate	Skin	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.